Multiple Sclerosis Journal (MSJ) is a scholarly journal dedicated to publishing research in the field of Neuroscience. SAGE is the publisher of this esteemed journal. The P-ISSN assigned to Multiple Sclerosis Journal is 1352-4585 and its abbreviated form is Mult Scler J Exp Transl Clin.
Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system. The journal for your research in the following areas: • Biologic basis: pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics, experimental models • Epidemology and genetics: genetics epigenetics, epidemiology • Clinical and Neuroimaging: clinical neurology, biomarkers, neuroimaging, Clinical Trials and clinical outcome measures, • Therapeutics and rehabilitation: therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management Outstanding information presented in a topical based format.
Journal title | Multiple Sclerosis Journal (MSJ) |
Abbreviation | Mult Scler J Exp Transl Clin |
Print ISSN | 1352-4585 |
Online ISSN | 1477-0970 |
Publisher Name | SAGE |
Editor-in-chief | Alan J Thompson |
Subject Category | Neuroscience |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Multiple Sclerosis Journal Journal is Mult Scler J Exp Transl Clin.
The Ranking of the Journal in 2024 is 2062. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 5.6. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 1.534. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 147. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
❌ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Mult Scler J Exp Transl Clin |
Access type | Hybrid |
Impact Factor | 5.6 |
SJR | 1.534 |
SNIP | 1.486 |
Ranking | 2062 |
CiteScore | 10.0 |
H-Index | 147 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is 4000
Call for paper : The Journal invites original research contributions for consideration of publication in Multiple Sclerosis Journal journal.
Journal seeking submissions in the broad areas of Neuroscience that align with journal's focus on Neuroscience.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Multiple Sclerosis Journal involves the following steps:
No, the journal is not indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 5.6.
The Ranking of the Journal is 2062.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Multiple Sclerosis Journal (MSJ) is a scholarly journal dedicated to publishing research in the field of Neuroscience. SAGE is the publisher of this esteemed journal.
Yes, Multiple Sclerosis Journal is a open access (Hybrid) journal.